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Abstract
The cell surface low-density lipoprotein receptor-related protein 1, LRP1, plays a major role in lipid metabolism. The
question that remains open concerns the function of LRP1 in adipogenesis. Here, we show that LRP1 is highly expressed in
murine preadipocytes as well as in primary culture of human adipocytes. Moreover, LRP1 remains abundantly synthesised
during mouse and human adipocyte differentiation. We demonstrate that LRP1 silencing in 3T3F442A murine preadipocytes
significantly inhibits the expression of PPARc, HSL and aP2 adipocyte differentiation markers after adipogenesis induction,
and leads to lipid-depleted cells. We further show that the absence of lipids in LRP1-silenced preadipocytes is not caused by
lipolysis induction. In addition, we provide the first evidences that LRP1 is significantly up-regulated in obese C57BI6/J
mouse adipocytes and obese human adipose tissues. Interestingly, silencing of LRP1 in fully-differentiated adipocytes also
reduces cellular lipid level and is associated with an increase of basal lipolysis. However, the ability of mature adipocytes to
induce lipolysis is independent of LRP1 expression. Altogether, our findings highlight the dual role of LRP1 in the control of
adipogenesis and lipid homeostasis, and suggest that LRP1 may be an important therapeutic target in obesity.
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Introduction
Consumption of meals rich in fat and carbohydrates is a major
causative factor of obesity, resulting in excessive white adipose tissue.
A d i p o s et i s s u es e r v e sa sa ne n e r g yr e s e r v o i ra n da sa ne n d o c r i n eo r g a n .
An increase of adipose tissue mass results from combined hypertrophy
of existing adipocytes (hypertrophic adipocytes) and adipogenic
differentiation of precursor cells (hyperplasic adipocytes) [1]. Expres-
sion of the nuclear peroxisome proliferator-activated receptor c
(PPARc) is known to be crucial for the initiation of adipocyte
differentiation. Indeed, mice with a targeted adipocyte-specific deletion
of the PPARc gene display a decreased adipose tissue mass [2].
Activation of PPARc induces the expression of lipogenic genes, such as
adipocyte fatty acid binding protein (aP2), and of lipolytic genes, such
as hormone-sensitive lipase (HSL) [3]. Interestingly, activated PPARc
also stimulates the transcription of the low-density lipoprotein receptor-
related protein 1 (LRP1) in adipocytes [4].
LRP1 is a 600-kDa multifunctional endocytic receptor that binds
and internalizes a broad range of biologically diverse ligands including
proteins important in lipoprotein metabolism [5]. LRP1 mediates the
endocytotic internalization of dietary lipids carried in postprandial
chylomicron remnants into hepatocytes by binding to Apolipoprotein
E (ApoE) [6,7], particle–bound lipoprotein lipase (LpL) [8] and hepatic
lipase [9]. Interestingly, LRP1 is expressed in adipocytes [4,10,11] and
insulin stimulation of LRP1 increases the endocytic uptake of
triglycerides and cholesteryl esters from remnant lipoproteins in
postprandial adipocytes in a synergistic action with lipoprotein lipase
[10]. Adipose-specific LRP1-knockout mice generated by crossing
LRP1
flox/flox mice with aP2-Cre transgenic mice recently revealed its
prominent role in lipid assimilation affecting energy metabolism and
diet-induced obesity in mature adipocytes [12]. Even through the
fundamental function of LRP1 in lipid homeostasis was recently
revealed in mouse model [12], its role in adipogenesis remains to be
elucidated. Here, we report that LRP1 expression is necessary for
adipocyte differentiation. Silencing of LRP1 in preadipocytes by the
use of siRNAs significantly inhibits the expression of PPARc,H S La n d
aP2 adipocyte differentiation markers, and leads to lipid-depleted cells
inept to induce lipolysis. Moreover, we corroborated the key function
of LRP1 in maintaining the lipid levels in mature adipocytes. Until
now, the implication of LRP1 in obesity has not been reported yet in
human. Our study highlights, for the first time, that LRP1 expression is
up-regulated in obese human tissue, and suggeststhat thisreceptormay
be an interesting therapeutic target in obesity.
Results
LRP1 is highly expressed in adipocytes during
adipogenesis in mouse and human
In order to explore the function of adipocytic LRP1, we first
investigated the level of LRP1 protein expression in preadipocytes
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7422relative to fibroblasts and epithelial cancer cells. As illustrated in
Figure 1A, LRP1 was abundantly expressed in preadipocytes (3T3-
F442A, 3T3-L1) and in fibroblasts (NIH-3T3,
LRP1+/2MEFs, HMF),
when compared to epithelial mammary immortalized (HMT3522-
S1) or cancer (MCF7, MDA-MB231) cells. As expected, no LRP1
expression was detected in
LRP12/2MEF cells (Fig. 1A).
To assess the role of LRP1 in preadipocytes, we next examined
the regulation of its expression during the course of adipogenesis
in the well-established murine 3T3F442A preadipocyte cell line,
which has been validated as a valuable model of adipogenesis [13]
(Fig. 1B–C). LRP1 mRNA (Fig. 1B) and LRP1b protein (Fig. 1C)
were expressed at high levels along adipogenesis. Even through, a
tendency of LRP1 up-regulation was observed, no statistical
significance was reached (Fig. 1B–C). To validate our experimental
conditions, we studied in parallel the expression of PPARc (Fig. 1B),
HSL (Fig. 1C) and aP2 (Fig. 1B) adipocyte markers of differenti-
ation. As attempted, the level of these markers was progressively
increased during acquisition of the adipocyte phenotype (Fig. 1B–
C). In addition, the cytoskeletal bactin protein amount was
diminished during adipocyte differentiation reflecting the change
in cellular morphology (Fig. 1C), as described before [14].
Although 3T3F442A cells are a valuable experimental model,
these preadipocytes have distinct attributes compared with human
cells in primary culture beyond the obvious species differences.
Therefore, we also analysed LRP1 expression during adipogenesis
in human preadipocytes purified from abdominal subcutaneous
adipose tissue using a recent approach [15] (Fig. 2). These primary
human cells were differentiated in an efficient manner since about
75% of preadipocytes were converted to the adipocyte phenotype
(Fig. 2A) and as reflected by HSL induction (Fig. 2B). As observed
for the mouse adipocyte, LRP1b protein remained abundantly
expressed along human adipocyte differentiation (Fig. 2B). Taken
together, these findings report the presence of high LRP1 levels
during adipocyte differentiation in both mouse and human.
Silencing of LRP1 expression inhibits adipogenesis
To determine whether preadipocyte requires LRP1 to differen-
tiate into mature adipocyte, LRP1 expression was silenced in
3T3F442A preadipocytes using 3 LRP1 siRNAs. As shown in
Figure 3A, a robust LRP1b extinction was observed two days post-
transfection with LRP1 siRNAs as compared to control Luc siRNA.
Consequently, we induced adipogenesis in control (Luc siRNA) and
LRP1-silenced 3T3F442A preadipocytes two days post-transfection
(Fig. 3B). As shown in Fig. 3B, LRP1b protein expression was
inhibited by the 3 LRP1 siRNAs as compared to Luc siRNA during
differentiation. The most efficient siRNA, LRP1 siRNA1, inhibited
LRP1b protein still after 7 days of differentiation (Fig. 3B). A
gradual lost of efficiency was observed with LRP1 siRNA2 and
siRNA3 at days 3, 5 and 7 days of differentiation (Fig. 3B). Similar
LRP1 silencing was observed at the mRNA level (Fig. 4A, panel a;
Fig. 4B, panel a), with a significant reduction of 74% and 50% for
LRP1 siRNA1 after 3 and 7 days of differentiation.
In order to evaluate the consequences of LRP1 silencing in
adipocyte differentiation, we first quantified the expression of
PPARc, HSL and aP2 adipocyte differentiation markers in Luc and
LRP1 siRNA transfected 3T3F442A cells (Fig. 4). LRP1 siRNA1
silencing (Fig. 4A, panel a) significantly inhibited PPARc (Fig. 4A,
panel b), HSL (Fig. 4A, panel c) and aP2 (Fig. 4A, panel d) mRNA
levels at days 3 and 7 of differentiation. Extinction of LRP1
expression by LRP1 siRNA2 and siRNA3 (Fig. 4B, panel a) also
reduced PPARc (Fig. 4B, panel b), HSL (Fig. 4B, panel c) and aP2
(Fig. 4B, panel d) mRNA levels at days 3 and 7 of differentiation but
to a lesser extend as compared to LRP1 siRNA1. Hence, our results
indicate that the gradual lost of LRP1 expression by LRP1 siRNAs
(Fig. 4B, panel a) led to a concomitant decrease of adipocyte
differentiation marker expression (Fig. 4B, panels b-d). Altogether,
these findings highlight that LRP1 tightly controls adipogenic
expression markers in a dose-dependent manner.
Figure 1. Expression of LRP1 in mouse adipocytes during
adipogenesis. (A) LRP1b protein expression. Expression of LRP1b,
and ERK2 were analysed by immunoblotting in preadipocytes (3T3-
F442A, 3T3-L1), fibroblasts (NIH-3T3,
LRP12/2MEF,
LRP1+/2MEF, HMF), and
epithelial (HMT3522-S1, MCF7, MDA-MB-231) cells. COS cells transfected
with LRP1b serve as a positive control for LRP1b expression. ERK2 was
used as a loading control. (B) LRP1 mRNA expression during
adipogenesis. RNA expression of LRP1, PPARc and aP2 were analysed
in exponentially growing 3T3F442A preadipocytes (Ex), in 3T3F442A
grown to confluence (Co) and after the indicated time of culture in
adipogenic differentiation medium by real-time quantitative RT-PCR.
Mean 6 SD of 5 independent experiments quantified in duplicate is
shown. LRP1 mRNA expression was not statistically different during
adipogenesis. (C) LRP1b protein expression during adipogenesis.
Protein expression of LRP1b, HSL, bactin and ERK2 were analysed by
immunoblotting in exponentially growing 3T3F442A preadipocytes (Ex)
and after the indicated time following induction of the differentiation
process. ERK2 was used as loading control. Similar results were
observed in 3 independent experiments. LRP1b protein expression
was not statistically different during adipogenesis.
doi:10.1371/journal.pone.0007422.g001
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or not for LRP1 (Fig. 5). Indeed, the most obvious feature of
adipocytes is the synthesis and storage of triglycerides in lipid
droplets and therefore the gradual appearance and growth of lipid
droplets are characteristic for adipocyte precursor cells undergoing
adipogenic differentiation. The presence of these neutral lipids was
detected by oil red O staining (Fig. 5A–B). As illustrated in Fig. 5A,
oil red O staining after 7 days of differentiation revealed that
extinction of LRP1 expression by siRNA1 strongly decreased
neutral lipid droplet formation and/or accumulation. Microscopic
analysis at day 3 and 7 of differentiation illustrated that, as
attempted, Luc siRNA-transfected 3T3F442A cells accumulated
numerous large lipid droplets and adopted a non adherent round
morphology characteristic of mature adipocytes (Fig. 5B, panels a
and c). By contrast, in 3T3F442A cells silenced with LRP1
siRNA1, the lipid droplet size and number were strongly reduced
(Fig. 5B, panels b and d). Moreover, cells kept the morphological
feature of adherent fibroblastic cells, suggesting that preadipocyte
differentiation process did not occur in the absence of LRP1.
Quantification of lipids afterwards demonstrated that silencing of
LRP1 with LRP1 siRNA1 significantly decreased lipid content
levels by 7 fold at day 7 of differentiation (Fig. 5C, panel a). LRP1
siRNA2 and siRNA3 also lowered the lipid content but to a lesser
extend as compared to LRP1 siRNA1 (Fig. 5C, panel a). Similar
results were obtained by quantifying triglycerides (Fig. 5C, panel
b). These results reveal that LRP1 silencing in preadipocytes
inhibits adipogenesis, leading to lipid-depleted cells.
We finally studied the effects of silencing LRP1 in preadipocyte
on lipolysis. Indeed, only mature adipocytes possess the complete
apparatus for lipolysis. Our results indicating a significant decrease
of HSL expression in LRP1 silenced cells (Fig. 4), we, therefore,
advocate that lipolysis should be absent in LRP1-silenced
preadipocytes. An alternative could be that LRP1 silenced cells
have an increased lipolysis, leading to lipid depleted cells.
However, our results revealed that glycerol release over 18 h
was significantly reduced in LRP1 silenced cells, indicating
inhibition of basal lipolysis (Fig. 6A). Moreover, glycerol and
NEFA released in the media after isoproterenol treatment were
also significantly decreased in LRP1 silenced cells, evidencing
inhibition of induced-lipolysis. Therefore, extinction of LRP1 in
preadipocytes abolishes expression of adipocyte differentiation
markers and leads to lipid-depleted cells inept to induce lipolysis.
LRP1 expression is up-regulated in human and mouse
obese adipose tissues
Obesity is characterized by the increase of intracellular lipid
accumulation which shows a significant correlation with adipocyte
differentiation. LRP1 mRNA expression was investigated in human
intra-abdominal visceral adipose tissue (VAT) from lean (42.764.5
year old, BMI: 23.163.3 kg/m
2) and obese (44.561.8 year old,
BMI: 47.661.3 kg/m
2) human (Fig. 7). Interestingly, LRP1 mRNA
was significantly increased in human obese adipose tissue (Fig. 7A).
To assess whether this LRP1 up-regulation was a general
characteristic of obese adipocytes, we then analysed LRP1 mRNA
Figure 2. Expression of LRP1 during adipogenesis in human. (A) Micrographs of human adipocytes. Human preadipocytes isolated from
subcutaneous adipose tissue digested with collagenase and separated from the stromal vascular fraction were grown for 0, 3, 7 and 14 days in the
presence of the adipogenic medium as illustrated in the micrographs. A representative experiment is shown. (B) LRP1b protein expression
during adipogenesis. Protein expression of LRP1b and HSL was analysed by immunoblotting after the indicated time following induction of the
differentiation process. NS, non specific band showing sample loading. Two independent experiments (left and right panels) are presented.
doi:10.1371/journal.pone.0007422.g002
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HFD or ND (Fig. 7B). As attempted HFD-fed C57BI6/J mice
exhibited a significant increase in body mass (47.661.4 g) when
compared to their controllittermates (31.161.2 g) (data not shown).
LRP1 expression was significantly enhanced in adipocytes of HFD
obese mice when compared to ND control mice (Fig. 7B).
Altogether, our results indicate that LRP1 expression is up-
regulated in human and mouse obese adipose tissues.
Silencing of LRP1 expression inhibits the cellular lipid
content of fully-differentiated adipocytes
Since we observed that LRP1 expression was up-regulated in
obese adipose tissues, we finally investigated whether extinction of
LRP1 expression in fully-differentiated adipocytes could diminish
their lipid content (Fig. 8), as recently suggested in adipose-specific
LRP12/2 mouse model [12]. 3T3F442A preadipocytes were
cultured for 10 days in adipogenic differentiation medium (Fig. 8A,
panel a) and fully-differentiated adipocytes were transiently
transfected with Luc siRNA or LRP1 siRNA1 (Fig. 8A, panel b).
Oil red O staining revealed that, after 7 days of culture, the lipid
droplet size and number were decreased in LRP1 siRNA1
transfected adipocytes (Fig. 8B–C). Quantification of lipids at
days 2 and 7 of culture revealed that, in Luc siRNA transfected
adipocytes, the level of cellular lipid remained unchanged whereas,
in LRP1 siRNA1 transfected cells, the amount of lipid was
significantly diminished by 27.8% (Fig. 8D). Interestingly, basal
lipolysis was significantly stimulated in LRP1 siRNA1 transfected
adipocytes (Fig. 9, panel a). We postulate that, since cells could not
internalized triglycerides in the absence of LRP1 as previously
shown [12], they were metabolizing their intracellular lipid stock.
However, induced lipolysis was not different in LRP1 and Luc
siRNA transfected cells (Fig. 9, panel b). Altogether, these findings
highlight, for the first time, the crucial role of LRP1 in controlling
adipogenesis and maintaining the lipid content in fully-differen-
Figure 3. Inhibition of LRP1 expression by silencing during adipocyte differentiation. (A) Silencing of LRP1 by siRNAs. 3T3F442A
preadipocytes were transiently transfected with Luc siRNA or LRP1 siRNAs. LRP1b protein expression was monitored by immunoblotting 2 days post-
transfection. a tubulin was used as a loading control. A representative experiment out of 3 is shown. (B) Time-course of LRP1b protein
expression after Luc siRNA or LRP1 siRNAs transfection during adipogenesis. 3T3F442A preadipocytes were transiently transfected with
Luc siRNA or LRP1 siRNAs. Two-days post-transfection, LRP1b protein expression was monitored by immunoblotting 0, 3, 5 or 7 days after
differentiation induction. ERK2 was used as a loading control.
doi:10.1371/journal.pone.0007422.g003
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therapeutic target in obesity.
Discussion
Here, we show that LRP1 is highly expressed in 3T3F442A
murine preadipocyte cell line, as previously described for 3T3L1
preadipocytes and embryonic fibroblasts [16,17]. Since LRP1 is
expressed at high levels in preadipocytes, it therefore can be
involved in the early steps of adipocyte differentiation. Indeed, our
report demonstrate that LRP1 silencing by siRNAs in 3T3F442A
preadipocytes significantly inhibits the expression of PPARc, HSL
and aP2 adipocyte markers of differentiation and leads to lipid-
depleted cells, indicating that LRP1 is a key regulator of the
Figure 4. Silencing of LRP1 inhibits expression of adipocyte differentiation markers in a LRP1 dose-dependent manner. (A) mRNA
expression of LRP1, PPARc, HSL and aP2 in LRP1 siRNA1-silenced preadipocytes. RNA expression of LRP1, PPARc, HSL and aP2 was analysed
in 3T3F442A preadipocytes transfected with LucsiRNA or LRP1 siRNA1. RNA was quantified by RT-PCR in 3T3F442Acells after 3 and7 days in adipogenic
differentiationmedium. Mean6 SD of 4 independent experiments is shown. *P,0.025when compared with LucsiRNAtransfectedcells. (B)Inhibition
of PPARc, HSL and aP2 mRNA expression in LRP1-silenced preadipocytes in a LRP1 dose-dependent manner. RNA levels of LRP1, PPARc,
HSL and aP2 in 3T3F442A preadipocytes transfected with Luc siRNA or the 3 LRP1 siRNA1-3 were performed as described in panel A.
doi:10.1371/journal.pone.0007422.g004
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that LRP1 extinction abrogates adipocyte differentiation in a
LRP1 dose-dependent manner. Our results also pinpoint that
extinction of LRP1 expression in pre-adipocytes prevents their
lipolytic response both at a basal level and after isoproterenol
induction. Therefore the inhibition of lipid accumulation and
triglyceride levels observed in LRP1-silenced preadipocytes is not
the consequence of a stimulation of lipolysis, indicating a direct
effect of LRP1 on the control of the adipogenic process. PPARc is
known to be crucial for the initiation of adipocyte differention [2].
Interestingly, PPARc has been described to induce LRP1
transcription [4] and our results indicate that LRP1 silencing
inhibits PPARc expression. This suggests the existence of a
regulatory loop between these two factors. Our findings reveal that
LRP1 silencing inhibits the expression of PPARc by 80% at day 3
of differentiation, indicating an early effect of LRP1 at the
commencement of adipogenesis. It is therefore important to
determine how LRP1 lost down-regulates PPARc expression. A
recent study demonstrates that LRP1 controls gene transcription
via Regulated Intramembrane Proteolysis through the cytoplasmic
Figure 5. LRP1 expression is required for adipogenesis. (A)
Staining of neutral lipids. Plates of 3T3F442A transfected with Luc
siRNA (panel a) or LRP1 siRNA1 (panel b) at day 7 are presented. Two-
days post Luc or LRP1 siRNA transfection, confluent 3T3F442A cells
were grown in the presence of the adipogenic differentiation medium.
After 7 days of differentiation, the extent of cellular lipid accumulation
was revealed by oil Red O staining. A representative experiment out of
3 is shown. (B) Micrographs of 3T3F442A preadipocytes. Cells
were transfected with Luc siRNA (panels a and c) or LRP1 siRNA1 (panels
b and d) and micrographs were performed after 3 (panels a and b) and
7 (panels c and d) days of differentiation. A representative experiment
out of 3 is shown. (C) Quantification of neutral lipids and
triglycerides. In panel a, lipid content was quantified at 3, 5 and 7
days of differentiation in 3T3F442A transfected with Luc or LRP1 siRNAs.
Mean 6 SD of 3 independent experiments is shown. *P,0.0025 when
compared with Luc siRNA transfected cells. In panel b, triglycerides
were quantified at day 5 and 7 of differentiation in 3T3F442A
transfected with Luc or LRP1 siRNAs. Results were normalised per mg
of DNA. Data are presented as mean 6 SD of an experiment performed
in triplicate. *P,0.0025 when compared with Luc siRNA transfected
cells.
doi:10.1371/journal.pone.0007422.g005
Figure 6. Silencing of LRP1 in pre-adipocytes inhibits lipolysis.
(A) Basal lipolysis. Glycerol release in the medium after 18 h was
quantified in 3T3F442A transfected with Luc or LRP1 siRNA1 after 7 days
of differentiation. Results were normalised with mg of DNA. Data are
presented as mean 6 SD of one experiment performed in quadrupli-
cate. P,0.025 when compared with Luc siRNA transfected cells. (B)
Induced lipolysis. Glycerol and non esterified fatty acid (NAFA)
releases were quantified after 7 days of differentiation in 3T3F442A cells
transfected with Luc or LRP1 siRNA1 and treated with increasing
concentrations of isoproterenol. Results were normalised per mgo f
DNA. Mean 6 SD of an experiment performed in quadruplicate is
presented. P,0.025 when compared with Luc siRNA transfected cells.
doi:10.1371/journal.pone.0007422.g006
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the future will investigate whether LRP1-ICD regulates PPARc
expression in preadipocytes.
Our results also indicate, for the first time, that LRP1 expression
is up-regulated in human obese tissue. This up-regulation of LRP1
expression in the VAT of overweight/obese patients is in
consensus with our results in obese mice. Obesity is characterized
by the increase of intracellular lipid accumulation which shows a
significant correlation with adipocyte differentiation. Terminally
differentiated adipocytes cannot divide. Hence, alterations in the
number of fat cells within the body must be accomplished by the
differentiation of preadipocytes, which act as a renewable source of
adipocytes. Interestingly, our in vitro study in 3T3F442A cells
indicates that LRP1 expression is required for adipocyte
differentiation and since LRP1 is abundantly expressed in
adipocytes, we propose that LRP1 may participate in the onset
of obesity. The crucial role of LRP1 in obesity is also supported by
a recent study showing that adipocyte LRP12/2 mice have an
overall decrease in fat mass and are protected from high-fat diet-
induced obesity [12]. Our experiments further show that silencing
Figure 7. LRP1 expression is up-regulated in human and mouse
obese adipose tissues. (A) LRP1 expression in adipose tissue
from lean and obese human. LRP1 mRNA level was quantified in
human intra-abdominal visceral adipose tissue samples (VAT) obtained
from 27 morbide grade III obese patients (44.5+/21.8 year old, BMI: 47.6
+/2 1.3 kg/m
2) before a bariatric surgery and from 10 control patients
undergoing abdominal lipectomy for plastic surgery (42.7 +/2 4.5 year
old, BMI: 23.1 +/2 3.3 kg/m
2). Results are mean values +/2 SEM,
*P,0.01 when compared with controls (normal VAT). (B) LRP1
expression in adipocytes from obese mouse. LRP1 mRNA level
was quantified in adipocytes isolated from intra-abdominal adipose
tissues from 30-week-old overweight C57Bl6/J mice fed in high-fat diet
(HFD) and from C57Bl6/J control mice fed in normal diet (ND). Results
are mean value +/2 SEM from 5 mice for ND group and 4 mice for HFD
group. *P,0.05 when compared with ND controls.
doi:10.1371/journal.pone.0007422.g007
Figure 8. LRP1 silencing in fully-differentiated adipocytes leads
to lipid-depleted cells. (A) Silencing of LRP1 in fully-differenti-
ated adipocyte. 3T3F442A pre-adipocytes were maintained for 10 days
inadipogenic differentiationmedium(panel a)andweretransfectedwith
Luc siRNA or LRP1 siRNA1. LRP1b protein expression was monitored by
immunoblotting 2 days post-transfection (panel b). ERK2 was used as a
loading control. (B) Staining of neutral lipids. Plates of differentiated
3T3F442A transfected with Luc siRNA (panel a) or LRP1 siRNA1 (panel b)
are shown. After siRNA transfection, 3T3F442A mature adipocytes were
grown in DMEM + 10% FCS. The extent of cellular lipid accumulation was
determined at day 2 and 7 of culture by oil Red O staining. A
representative experiment out of 3 is shown. (C) Micrographs of
3T3F442A adipocytes. Micrographs of differentiated adipocytes
transfected with Luc siRNA (panel a) or LRP1 siRNA1 (panel b) were
performed7 days post-transfection. A representative experiment outof 3
is shown. (D) Quantification of lipid content. Lipid content was
quantified at days 2 and 7 post-tranfection of differentiated adipocytes
transfected with Luc or LRP1 siRNA1. Mean 6 SD of 3 independent
experiments is shown. *P,0.005 when compared with Luc siRNA
transfected cells.
doi:10.1371/journal.pone.0007422.g008
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cellular lipid content, suggesting that LRP1 may be an important
therapeutic target in obesity. Most functional studies on adipocyte
differentiation and function have been performed in the murine
adipogenic 3T3L1 cell line and in genetically modified mice.
However, there are fundamental differences in the lipoprotein
metabolism of mouse and human [19]. Therefore, it is important
to investigate the LRP1 expression in human adipocytes as
presented in this report.
Results from the literature have suggested that LRP1 is a likely
contributor to adipogenesis, adipocyte homeostasis and obesity
given its high expression in adipocytes [4,10,11], that it binds
ApoE [7,8], LpL [20,21] and hepatic lipase [9], and that it
collaborates with heparin sulfate proteoglycans to mediate the
internalization of ApoE and LpL [22,23]. The dietary lipids are
carried in chylomicron remnants (CR) which are taken up into the
liver mainly via LRP1. LRP1 interacts with CR via ApoE [6,7] and
LpL in vitro and in vivo [8,24]. Interestingly, ApoE has been
reported to be crucial for the accumulation of triglycerides in
mouse adipocytes [25] and also appears to have an important
function in adipocyte differentiation [26] and obesity [27].
Altogether, these observations strongly suggest that a deregulation
of LRP1 expression may have important consequences in
adipocytes and obesity.
Some insight into LRP1 function in mature adipocyte was
obtained by generating mice with adipocyte-specific inactivation of
the LRP1 gene [12]. Adipocyte LRP1 knockout mice displayed
delayed postprandial lipid clearance, smaller fat stores, and lipid-
depleted adipocytes which resulted in reduced body weight due to
overall decrease in fat mass. This work highlights the importance
of adipocyte LRP1 in postprandial triglyceride metabolism, where
LRP1 in collaboration with LpL mediates both the endocytic and
lipolytic processes responsible for triglyceride catabolism
[23,28,29]. Our results are in accordance with this study and
indicate that extinction of LRP1 expression in mature adipocytes
leads to increased basal lipolysis. In addition, we show that the
capacity of mature adipocytes to induce lipolysis in response to
isoproterenol is not modified by LRP1 silencing. This suggests that
LRP1 does not directly control lipolysis. We propose that
inhibition of LRP1 expression stimulates basal lipolysis in order
to compensate the lack of lipid intake in the absence of LRP1.
Recently, it was shown that LRP1 is also required for lipolysis and
the control of intracellular cholesterol storage and fatty acid
synthesis via the Wnt5a signaling pathway in
LRP12/2MEF cells
[30].
In conclusion, our findings highlight that LRP1 plays a crucial
role in the control of adipogenesis and lipid homeostasis in mature
adipocytes. Moreover, our results indicate that LRP1 is up-
regulated in human obese tissues and mouse adipocytes.
Therefore, we propose that LRP1 targeting in obesity may lead
to a reduction of hypertrophic and hyperplasic adipocytes.
Materials and Methods
Ethics Statement
All subjects gave their informed written consent to participate to
the study, and investigations were performed in accordance with
the declaration of Helsinki as revised in 2000 (http://www.wma.
net/e/policy/b3.htm).
Cells and cell culture
Cell lines were cultured in DMEM (Invitrogen) supplemented
with 10% fetal calf serum (FCS). Differentiation was induced by
incubating 3T3F442A confluent cells in differentiation medium
(DMEM supplemented with 10% FCS and 50 nM insulin) as
described previously for up to 7 days [31]. After 7 days of
differentiation, cells were maintained in DMEM with 10% FCS.
Human samples
Human adipose tissue was collected according to the guidelines
of the Ethical Committee of Toulouse-Rangueil and Nancy J.
d’Arc Hospitals and received full ethical approval from the Ethical
Committee of Toulouse-Rangueil and Nancy J. d’Arc Hospitals.
All subjects gave their informed written consent to participate to
the study. Human abdominal visceral (VAT) adipose tissue
samples were obtained from 10 patients healthy volunteers (42.7
+/2 4.5 yr old, BMI: 23.1 +/2 3.3 kg/m
2) undergoing
abdominal lipectomy for plastic surgery. No clinical data from
these patients were available. Human abdominal visceral adipose
tissue samples were obtained from 27 morbidly (grade III) obese
subjects (44.5+/21.8 yr old, BMI: 47.6 +/2 1.3 kg/m
2) before a
bariatric surgery. All subjects were drug-free and besides obesity
they did not suffer of any disease. Tissue samples were
immediately frozen in liquid nitrogen and stored at 280uC. Total
RNAs of isolated adipocytes were extracted and LRP1 expression
analysed by RT-PCR. For in vitro differentiation, human
preadipocytes were isolated from human subcutaneous adipose
tissue obtained from patients undergoing abdominal lipectomy at
Figure 9. Analysis of lipolysis in fully-differentiated adipocytes
silenced for LRP1. Adipocytes differentiated for 10 days were
transfected with Luc siRNA or LRP1 siRNA1. Two days post-transfection,
glycerol release over 18 h (panel a) and glycerol and NEFA release after
isoproterenol stimulation (panel b) were quantified. Results were
normalised per mgo fD N A .M e a n6 SD of an experiment in
quadruplicate is shown. P,0.025.
doi:10.1371/journal.pone.0007422.g009
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France) under the agreement of local ethic committee. All subjects
gave their informed written consent to participate to the study.
Adipose tissue pieces were immediately used for collagenase
digestion as previously described [15]. The digestate was
centrifuged to separate adipocytes from the stroma-vascular
fraction, containing preadipocytes (pellet). Cells isolated from the
SVF fraction were induced to differentiate into adipocytes as
previously described [31]. Briefly, confluent cells (day 0) were
induced to differentiate in DMEM/Ham’s F12 (1:1) medium
containing 0.01 mg/ml transferrin, 100 nM cortisol, 0.2 nM
triiodothyronine, and 20 nM insulin. To trigger differentiation,
25 nM dexamethasone, 500 mM IBMX and 2 mM rosiglitazone
were present from day 0 to day 4. Intracellular accumulation of
lipid droplets became clearly evident at day 10 [15].
Mice
Mice were handled in accordance with the principles and
guidelines established by the National Institute of Medical
Research (INSERM). C57Bl6/J female mice were obtained from
Charles River laboratory (l’Arbresle, France). Mice were housed
conventionally in a constant temperature (20–22uC) and humidity
(50–60%) animal room and with a 12 h light–dark cycle. All mice
had free access to food and water throughout the experiment.
C57Bl6/J mice were assigned to normal-fat diet (ND) or high-fat
diet (HFD) (SAFE, France). Energy contents of the specific diets
were (% kcals): 20% protein, 70% carbohydrate, and 10% fat for
ND; 20% protein, 35% carbohydrate, and 45% fat for HFD. The
main source of fat in HFD was lard (20 g/100 g of food). C57Bl6/
J (10 week old) mice were fed a ND or HFD for 20 weeks. All mice
were sacrificed at 30 weeks of age.
Isolation of adipocytes from mouse adipose tissue
Mouse intra-abdominal adipose tissues were dissected immedi-
ately after sacrifice, minced in 5 ml of Dulbecco’s modified Eagle’s
medium (DMEM; Life Technologies, Inc., Invitrogen, Paisley,
UK) supplemented with 1 mg/ml collagenase (SIGMA) and 1%
BSA for 30 min at 37uC under shaking. Digestion was followed by
filtration through a 150 mm screen, and the floating adipocytes
were separated from the medium containing the stroma-vascular
fraction (SVF). Adipocytes were washed twice in DMEM and
further processed for RNA extraction using the RNeasy mini kit
(Qiagen, Germany).
Immunoblots
Cells were lysed in lysis buffer (50 mM HEPES pH 7.5,
150 mM NaCl, 10% glycerol, 1% Triton X100, 1.5 mM MgCl2,
1 mM EGTA, 100 mM NaF, 10 mM NaPPI, 500 mm Na-
Vanadate, 1 mM PMSF, 10 mM Aprotinine, and a protease
inhibitor cocktail). After gentle shaking for 20 min at 4uC, cell
extracts were obtained by centrifugation in a microfuge at
13,000 rpm for 15 min at 4uC. Equal amounts of protein
(100 mg) from cell extracts, quantitated by the Bradford assay,
were separated on a 7% gel by SDS-PAGE. Proteins were electro-
transferred to PVDF membrane and incubated with 1 mg/ml anti-
a tubulin (NeoMarkers), 1 mg/ml anti-b2actin (Sigma), 1 mg/ml
ERK2 (D-2, Santa Cruz Biotechnology), 11H4 anti-LRP1b
hybridoma (1/10 dilution, ATCC) or 0.4 mg/ml anti-HSL (Santa
Cruz). Proteins were then visualized with horseradish peroxidase-
conjugated sheep anti-mouse immunoglobulin (ECL Amersham)
or horseradish peroxidase-conjugated donkey anti-rabbit immu-
noglobulin (ECL Amersham) followed by the Renaissance
chemiluminescence system (Perkin Life Sciences).
RNA extraction and analysis
Total RNA was extracted using the RNeasy minikit (QIAGEN
Sciences, Maryland) according to the manufacturer’s instructions.
Reverse transcription of total RNA was performed at 37uC using
Moloney murine leukemia virus reverse transcriptase enzyme
(Invitrogen, Carlsbad, CA) and random hexanucleotide primers
(Promega, Madison, WI). Quantitative PCR was carried out by
real-time PCR using a LightCycler and the DNA double-strand-
specific SYBR green I dye for detection (Roche, Basel,
Switzerland). Results were normalized to RS9 levels. Sequences
of primers are:
mouse RS9 (sens 59CGGCCCGGGAGCTGTTGACG39,
reverse 59CTGCTTGCGGACCCTAATGTGACG39),
mouse aP2 (sens 59AACACCGAGATTTCCTTCAA39, re-
verse 59AGTCACGCCTTTCATAACACA39),
mouse LRP1 (sens 59GACCAGGTGTTGGACACAGATG39,
reverse 59AGTCGTTGTCTCCGTCACACTTC39),
mouse HSL (sens 59CTGAAGGCTCTGAGTTGGTCAA39,
reverse 59GGCTTACTGGGCACAGATACCT39),
mouse PPARc (sens 59 AGGCCGAGAAGGAGAAGCTG-
TTG39, reverse 59TGGCCACCTCTTTGCTCTGCTC39),
human LRP1 (sens 59TAGACCGGCCCCCTGTGCTGTTG-
A39, reverse 59GGTCTGCCGCGTGCTCGTAGGTGT39).
siRNAs and 3T3F442A transfection
Silencing of LRP1 gene expression in adipocytes was achieved by
the use of siRNAs. Duplexes of 21-nucleotide mouse LRP1 siRNA1
(target sequence AAGCATCTCAGTAGACTATCA) [32], mouse
LRP1 siRNA2 (target sequence AACTTCTTAAACTCATAGCTT)
(Dharmacon), mouse LRP1 siRNA3 (target sequence AAG-
CAGTTTGCCTGCAGAGAC) or firefly luciferase (Luc) siRNA
(target sequence AACGTACGCGGAATACTTCGA) were synthe-
sized by MWG Biotech S.A. (France). 2 10
6 3T3F442A mature
adipocytes were transiently transfected with 2 mg of siRNA using
Nucleofector Technology (Amaxa biosystems) according to the
manufacturer’s instructions using kit L (# VCA-1005) and were
replated in 2 wells of 6-well plates. After 48 h of transfection, cells have
recovered and were maintained in DEM 10% FCS for further analysis.
Analysis of LDH release monitored at 48 h revealed no toxicity of
transfecting mature adipocytes with LRP1 or Luc siRNAs (CytoTox96
Non-Radioactive Cytotoxicity Assay, Promega). For preadipocytes,
10
6 cells were transfected and were treated with insulin 48 h post-
transfection.
Oil Red O staining
3T3F442A adipocytes were washed with phosphate-buffered
saline (pH 7.4) and then fixed with Antigenfix (Diapath, Italy).
Cells were stained with Oil Red O dye (saturated Oil Red O dye
in six parts of isopropanol and four parts of water), an indicator of
cell lipid content, and then exhaustively rinsed with water.
Spectrophotometric quantification of lipids was performed by
dissolving the stained oil droplets with isopropanol and measuring
absorbance at 540 nm as previously described [33].
Quantification of triglycerides
Cells scraped in PBS were centrifugated for 5 min at 1200 rpm
at 4uC. Cell pellet was dissolved in 40 ml isopropanol and
centrifugated at 13 000 rpm for 5 min at 4uC. The supernatant
was used to determine the triglyceride content using the
Triglyceride FS kit (Diasys Diagnostic Systems, Germany)
according to the manufacturer’s instructions. The pellet was used
to quantify DNA concentration by a diaminobenzoic aci
fluorescence assay [34].
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Cells were incubated in DMEM without serum in the presence
of 2% fatty acid-free bovine serum albumin (A7030, Sigma)
overnight. Fresh medium containing isoproterenol was added for
90 min. Glycerol and NEFA contents in the medium were
measured with free glycerol reagent (F6428 Sigma) and NEFA C
kit (Wako Chemicals, Germany).
Statistical analysis
Results are expressed as means 6 SEM. Statistical differences
between two groups were evaluated using Student’s t tests. The
level of significance was set at P,0.05.
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